Rituxan Fails to Treat Moderate to Severe SLE without Kidney Involvement, Trial Reanalysis Confirms
Rituxan (rituximab) is not effective at treating moderate to severe systemic lupus erythematosus (SLE) patients without kidney involvement, a new analysis of the Phase 2/3 trial EXPLORER concluded. The results confirm a prior analysis…